Phototherapy for atopic dermatitis: A survey of European practice.
M SteynL A A GerbensP I SpulsS MashayekhiMette DeleuranSébastien BarbarotAndreas WollenbergJ FergusonSally Helen IbbotsonCarsten FlohrPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
NBUVB was the most widely used phototherapy for AD in adult and paediatric patients, while PUVA and UVA1 were less used. Prescribing practices varied considerably, highlighting the lack of consensus practice in many different aspects of phototherapy for the treatment of AD in children and adults. This indicates that further studies are required to determine optimal phototherapeutic regimens for AD and informs our understanding of parameters that should be included in future high-quality randomized controlled trials (RCT) of phototherapy.
Keyphrases
- primary care
- healthcare
- end stage renal disease
- atopic dermatitis
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- newly diagnosed
- emergency department
- peritoneal dialysis
- prognostic factors
- young adults
- quality improvement
- clinical trial
- clinical practice
- patient reported outcomes
- current status
- double blind